logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hiromichi Maeda

kochi university
H指数:28
被引数:2,965

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of oral 5-FU-based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer

口服5-FU为基础的辅助化疗对老年结直肠癌患者的疗效与安全性：日本多学科治疗癌症基金会开展的七项临床试验的整合分析

Colorectal Disease
IF2.7
2025-11-010
OAAI
Hoshino, Nobuaki; Kanda, Mitsuro; Oba, Koji; Aoyama, Toru; Honda, Michitaka; Kashiwabara, Kosuke; Maeda, Hiromichi; Mayanagi, Shuhei; Muto, Masaru; Tanaka, Kenji; Yamagishi, Hisakazu; Sakamoto, Junichi; Obama, Kazutaka; Yoshikawa, Takaki
Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials

术后辅助化疗的不良事件预测局部晚期结直肠癌的生存结局：一项日本临床试验的合并分析

British Journal of Cancer
IF6.8
2025-09-220
OAAI
Hidetaka Kawamura; Michitaka Honda; Yujiro Nakayama; Koji Oba; Masaru Muto; Toru Aoyama; Mitsuro Kanda; Hiromichi Maeda; Shuhei Mayanagi; Kosuke Kashiwabara; Kenji Tanaka; Junichi Sakamoto; Hisakazu Yamagishi; Takaki Yoshikawa
Surgical Volume and Short-Term Outcomes After Advanced Hepatectomy in the Postpandemic Era: Analysis of the Japanese National Clinical Database (2018–2023)

后疫情时代复杂肝切除术后的手术量与短期结局：基于日本国家临床数据库（2018–2023）的分析

Annals of Gastroenterological Surgery
IF3.3
2025-06-100
OAAI
Yusuke Takemura; Hideki Endo; Taizo Hibi; Ryo Seishima; Masashi Takeuchi; Hiroyuki Yamamoto; Hiromichi Maeda; Akinobu Taketomi; Yoshihiro Kakeji; Yasuyuki Seto; Hideki Ueno; Masaki Mori; Ken Shirabe; Yuko Kitagawa
A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study

一项多中心、随机、开放标签的2期研究，旨在探讨接受trastuzumab deruxtecan治疗的晚期/复发性胃癌患者的最佳止吐疗法：EN-hance研究

international journal of oncology
IF2.8
2025-04-280
OA
Aoyama, Toru; Ooki, Akira; Oba, Koji; Nishikawa, Kazuhiro; Kawabata, Ryohei; Honda, Michitaka; Maeda, Hiromichi; Kanda, Mitsuro; Sugiyama, Keiji; Makiyama, Akitaka; Segami, Kenki; Takahashi, Masazumi; Shindo, Yoshiaki; Namikawa, Tsutomu; Oshima, Takashi; Katayama, Aya; Shiosakai, Kazuhito; Sakamoto, Junichi
Nationwide Trends in Short-Term Outcomes After Low Anterior Resection for Rectal Cancer: A Pre- and Post-COVID-19 Analysis From the Japanese National Clinical Database, 2018-2023

日本国家临床数据库中结直肠癌经低位前切除术后短期结局的全国趋势：基于2018-2023年COVID-19前后分析

ANNALS OF GASTROENTEROLOGICAL SURGERY
IF3.3
2025-04-250
OAAI
Ryo Seishima; Hideki Endo; Hiromichi Maeda; Taizo Hibi; Masashi Takeuchi; Yusuke Takemura; Hiroyuki Yamamoto; Akinobu Taketomi; Yoshihiro Kakeji; Yasuyuki Seto; Hideki Ueno; Masaki Mori; Ken Shirabe; Yuko Kitagawa
Impact of the COVID-19 pandemic on the short-term outcomes after advanced liver resections performed in institutions certificated by Japanese Society of Hepato-Biliary-Pancreatic Surgery: Results from the Japanese National Clinical Database, 2018-2022
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
IF2.8
2025-03-010
PRE
Takemura, Yusuke; Endo, Hideki; Hibi, Taizo; Seishima, Ryo; Takeuchi, Masashi; Yamamoto, Hiroyuki; Maeda, Hiromichi; Hanazaki, Kazuhiro; Taketomi, Akinobu; Kakeji, Yoshihiro; Seto, Yasuyuki; Ueno, Hideki; Endo, Itaru; Ohtsuka, Masayuki; Mori, Masaki; Shirabe, Ken; Kitagawa, Yuko
Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2022-07-054
PRE
Watanabe, Jun; Maeda, Hiromichi; Nagasaka, Takeshi; Yokota, Mitsuru; Hirata, Keiji; Akazawa, Naoya; Kagawa, Yoshinori; Yamada, Takeshi; Shiozawa, Manabu; Ando, Takayuki; Kato, Takeshi; Mishima, Hideyuki; Sakamoto, Junichi; Oba, Koji; Nagata, Naoki
Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer

CapeOX联合西妥昔单抗作为RAS/BRAF/PIK3CA野生型晚期或转移性结直肠癌患者一线治疗的疗效

JOURNAL OF CANCER
IF3.2
2018-01-016
OAAI
Iwamoto, Shigeyoshi; Maeda, Hiromichi; Hazama, Shoichi; Oba, Koji; Okayama, Naoko; Suehiro, Yutaka; Yamasaki, Takahiro; Suzuki, Nobuaki; Nagano, Hiroaki; Sakamoto, Junichi; Mishima, Hideyuki; Nagata, Naoki

研究方向

暂未获取到该数据
K
Kazuhiro Hanazaki
H 指数:45论文数:591被引数:8,038
K
Koji Oba
H 指数:47论文数:428被引数:9,021
T
Takehiro Okabayashi
H 指数:38论文数:291被引数:5,319
T
Tsutomu Namikawa
H 指数:29论文数:345被引数:3,352
M
Michitaka Honda
H 指数:29论文数:225被引数:3,143
T
Toru Aoyama
H 指数:45论文数:543被引数:7,084
M
Michiya Kobayashi
H 指数:35论文数:474被引数:5,357
T
Takaki Yoshikawa
H 指数:63论文数:864被引数:1.9万
J
Junichi Sakamoto
H 指数:45论文数:409被引数:6,985
Y
Yoshihiro Kakeji
H 指数:70论文数:1,076被引数:2.0万